Pembrolizumab,Lenvatinib,Sunitinib
Merck,Pfizer,eisai
['rcc,(-irccs),(-srcc),(-urcc)']
#esmo22 excellent points raised by on the selection of therapy in 1st line rx setting in mrcc #kidneycancer : efficacy and toxicities of various approved regimes 
Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI https://t.co/qcdl195o3E